CRITICAL PERSPECTIVE ON THE TREATMENT OF STAGE IV NON-SMALL CELL LUNG CANCER: COST ANALYSIS OF NEW DRUGS
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 2011
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Thoracic Oncology Journal